Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas.
about
Fusion of the TBL1XR1 and HMGA1 genes in splenic hemangioma with t(3;6)(q26;p21)Clinicopathologic significance of MYD88 L265P mutation in diffuse large B-cell lymphoma: a meta-analysis.Bing-Neel Syndrome with Detectable MYD88 L265P Gene Mutation as a Late Relapse Following Autologous Hematopoietic Stem Cell Transplantation for Waldenström's MacroglobulinemiaSurvival of human lymphoma cells requires B-cell receptor engagement by self-antigens.TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy.Cerebrospinal Fluid IL-10 and IL-10/IL-6 as Accurate Diagnostic Biomarkers for Primary Central Nervous System Large B-cell Lymphoma.Clinical Impact of the 2016 Update to the WHO Lymphoma Classification.Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma.Expression of Tim-1 in primary CNS lymphoma.How we diagnose and treat vitreoretinal lymphoma.Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma.Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphoma.Mutational profile of primary breast diffuse large B-cell lymphoma.Mapping the human T cell repertoire to recurrent driver mutations in MYD88 and EZH2 in lymphoma.Frequency of MYD88 and CD79B mutations, and MGMT methylation in primary central nervous system diffuse large B-cell lymphoma.Treatment of initial parenchymal central nervous system involvement in systemic aggressive B-cell lymphoma.Clinical significance of disease-specific MYD88 mutations in circulating DNA in primary central nervous system lymphoma.Mutational frequencies of CD79B and MYD88 vary greatly between primary testicular DLBCL and gastrointestinal DLBCL.MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.Primary CNS Lymphoma.A multiprotein supercomplex controlling oncogenic signalling in lymphomaAnalysis of Genomic Alteration in Primary Central Nervous System Lymphoma and the Expression of Some Related Genes
P2860
Q28600956-74EED44A-6899-4E6B-95F4-72A300D063A5Q33687549-0FB23DFA-B26B-42B2-BF60-EFDC84636EE6Q33716510-05D4EEDF-1B17-4C75-8945-48BAE864C5FDQ36268482-AE5FF131-C03B-41D4-8EBE-637ACC080933Q36825602-588A0B62-754D-42E1-A040-D7B82B08B4DEQ37479559-AE926749-19B6-47EB-A4E3-EE2F793F1438Q38663689-D8976F09-72C1-4F03-BD8F-E3C40AE1BB31Q38723290-FCF4AC96-13CE-4D81-9908-5FCED997D740Q38742256-7C6484C2-3EB8-4B52-9A47-AD36D9830261Q38822438-96E692F3-7A3C-49D8-9D4A-7C8208E6EB3EQ40182586-385BA1CF-4345-4D1A-9465-0705D27A27B5Q41471491-2EA6C66A-1899-4ADD-AFC9-03D5E2D16270Q47118882-4FEA35DA-4377-4172-9D8E-26C1214A0031Q47947510-E311B8E6-7490-408B-8238-62015CF91CBCQ48151021-8B65F67A-83EE-4549-A635-F16060B36550Q48270985-6BFB14A8-8F08-430B-BE87-23386C80C4C6Q48277300-C900C3AB-3AE9-445A-A295-919B5B1B7F82Q50226517-54255C2B-D4AC-47B7-8377-336F4F16979BQ51286673-F03BC90E-9A67-41BD-893F-F8E3C338CC29Q51841565-6AB3C5D9-E15D-48C5-AE17-9A5EAF3ED568Q57759535-4FE9E697-2AA9-4F58-962C-2E777776A374Q58737485-B1AC1B66-A261-4FCA-A2A1-EF900505E8A4
P2860
Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Recurrent mutations of CD79B a ...... tral nervous system lymphomas.
@en
Recurrent mutations of CD79B a ...... tral nervous system lymphomas.
@nl
type
label
Recurrent mutations of CD79B a ...... tral nervous system lymphomas.
@en
Recurrent mutations of CD79B a ...... tral nervous system lymphomas.
@nl
prefLabel
Recurrent mutations of CD79B a ...... tral nervous system lymphomas.
@en
Recurrent mutations of CD79B a ...... tral nervous system lymphomas.
@nl
P2093
P2860
P356
P1476
Recurrent mutations of CD79B a ...... ntral nervous system lymphomas
@en
P2093
K Ichimura
K Tateishi
N Hashimoto
N Kawahara
P2860
P304
P356
10.1111/NAN.12259
P577
2015-07-20T00:00:00Z